Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand
Fierce editors discuss a major blow to Eli Lilly's late-stage pipeline, Mylan's ongoing courtship of Perrigo, and Merck KGaA's big push to distance itself from that other Merck.
About This Episode
Lilly's latest pipeline peril, Mylan's M&A broken record, and German Merck's big rebrand is an episode from FierceBiotech Radio. Fierce editors discuss a major blow to Eli Lilly's late-stage pipeline, Mylan's ongoing courtship of Perrigo, a...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Oct 15, 2015, 28:55 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
